Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1988-9-21
|
pubmed:language |
pol
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0022-9032
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
30 Suppl
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
97-105
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3331405-Adult,
pubmed-meshheading:3331405-Aged,
pubmed-meshheading:3331405-Clinical Trials as Topic,
pubmed-meshheading:3331405-Double-Blind Method,
pubmed-meshheading:3331405-Humans,
pubmed-meshheading:3331405-Middle Aged,
pubmed-meshheading:3331405-Nifedipine,
pubmed-meshheading:3331405-Raynaud Disease
|
pubmed:year |
1987
|
pubmed:articleTitle |
[Use of nifedipine in patients with Raynaud's phenomenon].
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
English Abstract
|